IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Schering-Plough to Buy Akzo’s Pharma Unit

11:52 AM MDT | July 26, 2007 | Alex Scott and Kerri Walsh

Akzo Nobel says it has agreed to sell its pharmaceuticals business Organon BioSciences (OBS) to Schering-Plough for €11 billion ($14.5 billion). The companies expect the deal to be completed in the second half, following regulatory approval. The divestiture would provide Akzo with extra cash, which has rekindled some expectations that Akzo plans to bid for ICI, media reports say. The deal will fill a gap in Schering-Plough’s late-stage drug development pipeline by adding five compounds in Phase III development and several “promising projects in...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa